Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases
8/1 12:30
Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to 20 novel drug programmes in obesity,...
Læs mere »...